Skip to main content

MoneyWorks4Me

Rubra Medicaments - Quaterly Results

07 Feb 2024 Evaluate
The sales declined to Rs. 1.70 millions for the December 2023 quarter as compared to Rs. 2.10 millions during the corresponding quarter last year.Net Profit for the quarter ended December 2023 zoomed to 5600.00% from Rs. 0.01 millions to Rs. 0.57  millions.OP of the company witnessed a marginal growth to 0.59 millions from 0.01 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1.70 2.10 -19.05 6.60 10.80 -38.89 11.60 20.11 -42.32
Other Income 0.01 0.01 0.00 0.01 0.01 0.00 0.02 0.01 100.00
PBIDT 0.59 0.01 5800.00 2.67 0.32 734.38 -0.78 -0.21 271.43
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.59 0.02 2850.00 2.67 0.33 709.09 -0.78 -0.21 271.43
Depreciation 0.02 0.01 100.00 0.06 0.01 500.00 0.03 0.02 50.00
PBT 0.57 0.01 5600.00 2.61 0.32 715.63 -0.81 -0.23 252.17
TAX 0.00 0.00 0.00 -0.01 0.08 -112.50 -0.02 0.14 -114.29
Deferred Tax 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00
PAT 0.57 0.01 5600.00 2.62 0.24 991.67 -0.79 -0.37 113.51
Equity 54.68 54.68 0.00 54.68 54.68 0.00 54.68 54.68 0.00
PBIDTM(%) 34.71 0.48 7188.09 40.45 2.96 1265.32 -6.72 -1.04 543.89
Peers
Company Name CMP
Redington 358.60
Adani Enterprises 2736.00
Amrapali Industries 34.77
Maxgrow India 178.35
Rashi Peripheral 697.90
View more..